This rise likely assists the endothelial-tumour interactions for seeding and settling of cancer cells in the brain and is supported by additional evidence that anti-ALCAM antibodies significantly inhibited the number of metastatic tumours in the brain [120]. This evidence concerns the gene ALCAM and cancer.